Normal
6th - 7th October 2022

MarketsandMarkets Precision Medicine Conference

London, UK

The Evolution of Targeted Therapy & Personalized Medicine

The healthcare sector is accelerating on a trajectory from ubiquitous treatment to truly personalized treatment. The advent of precision medicine has paved ways for customization and preventive health strategy development by utilizing the genetic information of the individual along with ethnicity, environment exposures, medical history and more. Surging trends in tailoring care have been a driving force for extensive research in this field from data research to target drug discovery. Advancement in pharmacogenomics and genomic technologies has allowed the clinicians to design specific treatment strategy for specific disease at the specific time.

 

MarketsandMarkets is delighted to announce its Precision Medicine Conference scheduled to be held on 6th – 7th October 2022 in London, UK. The conference is intended to have interactive sessions on precision medicine, application of pharmacogenomics, complex diseases prediction and treatment, technological advancements in diagnosis of diseases, artificial intelligence and bigdata, challenges and ethical considerations in precision medicine. The event encompasses networking sessions, panel discussions, solutions, and services catering to precision medicine. The conference will bring the full spectrum of experts, leaders, and stakeholders to share a board prospective on opportunities and overcoming the challenges faced during implementation of precision medicine in clinical practice.

WHAT TO EXPECT

Key Highlights

  • Overview of Precision Medicine and Genomic Science
  • Precision Medicine in complex disease prediction and treatment – Chronic diseases, CAR T- cell immunotherapy in solid tumors
  • Comprehensive Genomic profiling 
  • Use of digital biomarkers for drug development, Multi-Omics prospects (Epigenomics, Proteomics, Transcriptomics, Pharmaco genomics)
  • Inception of technologies for Precision Medicine – Big Data, AI, ML, Insilico trials.
  • Regulatory, Ethical and Social challenges.

Why Attend ?

  • Quality insights and cohesiveness of key issues and obstacles experienced by the healthcare providers while implementing precision medicine.
  • Comprehend the current and future regulatory prospects for approval of diagnostic tests.
  • Discuss the emerging technologies and opportunities with cutting edge strategies.
  • Insightful panel discussions & a chance to network with leaders & peers from the industry.
  • Witness LIVE, how precision medicine is revolutionizing the future of healthcare.

CONFERENCE AGENDA
END OF DAY 1 followed by Drinks, Reception and Networking
Precision Medicine in Disease Prediction & Treatment
Precision Medicine and Pharmacogenomics
Future Purview of Precision Medicine
END OF DAY 2
CONFERENCE SPEAKERS
Advisors
Alex F Frangi
Alex F Frangi
Diamond Jubilee Chair in Computational Medicine & RAEng Chair in Emerging Technologies, University of Leeds & KU Leuven - Turing Fellow
Joanne M. Hackett
Joanne M. Hackett
Head of Genomic and Precision Medicine, IQVIA
Manuel Corpas
Manuel Corpas
Chief Scientist, Genome Bioinformatician , Cambridge Precision Medicine
Speakers
Alex F Frangi
Alex F Frangi
Diamond Jubilee Chair in Computational Medicine & RAEng Chair in Emerging Technologies, University of Leeds & KU Leuven - Turing Fellow
John Maher
John Maher
Leucid Bio, Scientific Founder and Chief Scientific Officer
Steve Gardner
Steve Gardner
CEO, PrecisionLife, UK
Jenny Barnett
Jenny Barnett
CEO, Monument Therapeutics
LOCATION
London, UK
About the Hotel

PAST EVENT GALLERY